Pampa Energia S.A. (NYSE:PAM), announces that It will hold a General Ordinary Shareholders’ meeting on first and second call, on April 30, 2014, at 11:00 a.m. and 12:00 noon, respectively, in all cases at the registered office, located at Ortiz de Ocampo 3302, Building 4, Ground Floor, City of Buenos Aires. Pampa Energia S.A. (ADR) (NYSE:PAM) shares after opening at $6.29 moved to $6.31 on last trade day and at the end of the day closed at $6.10. Company price to sales ratio in past twelve months was calculated as 0.55 and price to cash ratio as 3.54. Pampa Energia S.A. (ADR) (NYSE:PAM) showed a positive weekly performance of 8.93%.
UBIC, Inc (ADR) (NASDAQ:UBIC) saw a big move last session, as the company’s shares fell over 5% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for UBIC as the stock is now up nearly 26% in the past one-month time frame. Ubic Inc (ADR) (NASDAQ:UBIC) shares fell -1.40% in last trading session and ended the day on $6.36.
Analysts at Zacks initiated coverage on shares of Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) in a research note on Wednesday, March 5th. They set a “hold” rating on the stock. Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) shares moved down -6.78% in last trading session and was closed at $23.50 while trading in range of $23.36 – $25.72 – Dicerna Pharmaceuticals Inc (NASDAQ:DRNA) year to date (YTD) performance is -45.85%.
PTC Therapeutics (NASDAQ:PTCT) CEO Stuart Walter Peltz sold 25,487 shares of the company’s stock on the open market in a transaction that occurred on Monday, March 24th. The stock was sold at an average price of $29.86, for a total value of $761,041.82. PTC Therapeutics, Inc. (NASDAQ:PTCT) weekly performance is -12.32%. On last trading day company shares ended up $23.84. PTC Therapeutics, Inc. (NASDAQ:PTCT) distance from 50-day simple moving average (SMA50) is -15.89%. Analysts mean target price for the company is $42.50.